118 related articles for article (PubMed ID: 14616291)
1. Promoter polymorphism of IL-10 and severity of multiple sclerosis.
Luomala M; Lehtimäki T; Huhtala H; Ukkonen M; Koivula T; Hurme M; Elovaara I
Acta Neurol Scand; 2003 Dec; 108(6):396-400. PubMed ID: 14616291
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression.
Almeras L; Meresse B; Seze J; De Lefranc D; Dubucquoi S; Fajardy I; Vermersch P; Prin L
Eur Cytokine Netw; 2002; 13(2):200-6. PubMed ID: 12101075
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis.
Pickard C; Mann C; Sinnott P; Boggild M; Hawkins C; Strange RC; Hutchinson IV; Ollier WE; Donn RP
J Neuroimmunol; 1999 Nov; 101(2):207-10. PubMed ID: 10580805
[TBL] [Abstract][Full Text] [Related]
4. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
[TBL] [Abstract][Full Text] [Related]
5. Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.
Shahbazi M; Abadi JSA; Roshandel D; Koochaki M; Amiri H; Kohansal R; Baghbanian SM; Zamani M
Indian J Med Res; 2017 Jun; 145(6):746-752. PubMed ID: 29067976
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis.
Mäurer M; Kruse N; Giess R; Toyka KV; Rieckmann P
J Neuroimmunol; 2000 Apr; 104(1):98-100. PubMed ID: 10683520
[TBL] [Abstract][Full Text] [Related]
7. The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
Orhan G; Eruyar E; Mungan SÖ; Ak F; Karahalil B
Clin Neurol Neurosurg; 2016 Jul; 146():96-101. PubMed ID: 27177146
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients.
Akcali A; Pehlivan S; Pehlivan M; Sever T; Akgul P; Neyal M
Int J Immunogenet; 2010 Apr; 37(2):91-5. PubMed ID: 20082645
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 Promoter and the CCR5 Polymorphisms in Iranian Azari Population with Multiple Sclerosis.
Asgharzadeh M; Sanajoo D; Mahdavi Poor B; Samadi Kafil H; Gholizadeh P; Rashedi J
Iran J Immunol; 2021 Sep; 18(3):241-248. PubMed ID: 34596589
[TBL] [Abstract][Full Text] [Related]
10. The rs3761548 FOXP3 variant is associated with multiple sclerosis and transforming growth factor β1 levels in female patients.
Flauzino T; Alfieri DF; de Carvalho Jennings Pereira WL; Oliveira SR; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; de Oliveira KB; Simão ANC; Reiche EMV
Inflamm Res; 2019 Nov; 68(11):933-943. PubMed ID: 31414141
[TBL] [Abstract][Full Text] [Related]
11. Search for genetic factors associated with susceptibility to multiple sclerosis.
Forte GI; Ragonese P; Salemi G; Scola L; Candore G; D'Amelio M; Crivello A; Di Benedetto N; Nuzzo D; Giacalone A; Lio D; Caruso C
Ann N Y Acad Sci; 2006 May; 1067():264-9. PubMed ID: 16803996
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 polymorphisms in Spanish multiple sclerosis patients.
Martinez Doncel A; Rubio A; Arroyo R; de las Heras V; Martín C; Fernandez-Arquero M; de la Concha EG
J Neuroimmunol; 2002 Oct; 131(1-2):168-72. PubMed ID: 12458048
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: A meta-analysis.
Ramakrishnan V; Akram Husain RS; Ahmed SS
J Neuroimmunol; 2017 May; 306():11-18. PubMed ID: 28385181
[TBL] [Abstract][Full Text] [Related]
14. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
[TBL] [Abstract][Full Text] [Related]
15. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
[TBL] [Abstract][Full Text] [Related]
16. IL-10 polymorphism is associated with increased incidence of severe sepsis.
Shu Q; Fang X; Chen Q; Stuber F
Chin Med J (Engl); 2003 Nov; 116(11):1756-9. PubMed ID: 14642153
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.
Myhr KM; Vågnes KS; Marøy TH; Aarseth JH; Nyland HI; Vedeler CA
J Neurol Sci; 2002 Oct; 202(1-2):93-7. PubMed ID: 12220699
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients.
Hattori N; Niimi T; Sato S; Achiwa H; Maeda H; Oguri T; Bessho Y; Ito H; Shimizu S; Ueda R
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):27-32. PubMed ID: 15881277
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis.
Lagha A; Zidi S; Stayoussef M; Gazouani E; Kochkar R; Kochbati S; Almawi WY; Yacoubi-Loueslati B
Pathol Biol (Paris); 2015 Sep; 63(4-5):179-84. PubMed ID: 26003199
[TBL] [Abstract][Full Text] [Related]
20. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients.
Mihailova S; Ivanova M; Mihaylova A; Quin L; Mikova O; Naumova E
J Neuroimmunol; 2005 Nov; 168(1-2):138-43. PubMed ID: 16183136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
